GMP News - Packaging

06.05.15

Warning letter due to insufficient container-/closure integrity

A site of the company Hospira in Italy received an FDA Warning Letter at the end of March which criticises among others defects concerning the closure of vials and the related possible microbiological contaminations. Read more about the Warning Letter.

29.04.15

Update of the USP Requirements for Packaging Materials made of Plastics

In the Pharmacopeial Forum the USP has described the future requirements for packaging materials made of plastics. The original proposals were now revised, and new proposals were published with regard to the structure and content of the General Chapters on packaging materials made of plastics. For more information please see the Update of the USP Requirements.

18.03.15

BS EN 16679 for the Review of Manipulations on Medicinal Product Packaging issued

The completely new created norm BS EN 16679 has now been available at British Standards since December 2014. It is supposed to support the use and implementation of the EU Counterfeit Directive. Read more about the BS EN 16679 for the Review of Manipulations on Medicinal Product Packaging.

28.01.15

Leakages in Ampoules cause Recalls

There have been several recalls of sterile ampoules in Switzerland. The manufacturer stated a possible leakage as reason for the recall. Read more.

10.12.14

Corrigendum of the EU Counterfeit Directive

In the Official Journal of the European Union from 9 August 2014, two corrigenda to the counterfeit directive have been published with regard to the prevention of the entry into the legal supply chain of falsified medicinal products. Please read more details here in this News.

12.11.14

New USP Requirements on Plastic Packaging Systems

The USP describes in an article of the Pharmacopeial Forum the future requirements for plastic packaging systems. Here, the importance is laid on the selection of suitable, safe plastic materials and the verification of potential interactions. More information can be found here in the News.

20.08.14

What does the FDA say regarding glass delamination prevention?

Delamination is a phenomenon that can occur repeatedly in glass containers. The glass particles emitted into the solution can pose a risk especially for parenteral drugs. Read the current view of the FDA on this topic.

30.04.14

Pharmaceutical Packaging - New USP Proposal for Optimised Method of Measuring Moisture Vapour Permeation

An improved method of measuring water vapour permeation for solid oral dosage forms like tablets or capsules has been discussed during a USP - PQRI Workshop and presented in the Pharmacopeial Forum. See the detailed information.

Page 9 of 9

« First
Previous
3
4
5
6
7
8
9

Process Understanding - Statistical Process Control (SPC) as a tool to get there

Recommended Event

Heidelberg, Germany

25/26 January 2023